US 10941208
Anti-MUC16 antibodies
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 10941208 (Anti-MUC16 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/6849